BioMark - Cancer Research Services
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck Cancer.
-
Most popular related searches
Details
Application:
- Screening for high risk group
- Precision medicine
- Assess high risk relapse population cohort
- Assess malignancy
Clinical Trials:
Spermidine/spermine N-acetyltransferase 1 (SSAT 1) Gene Expression in Human Cancer
Principal Investigator: Dr. Andrew Maksymiuk, MD, Cancer Care Manitoba
Status: Open
Spermidine/spermine N-acetyltransferase 1 (SSAT1) Gene Expression and Identification of High-Performance Metabolites in Human Cancer (Amended)
Principal Investigator: Dr. Andrew Maksymiuk, MD, Cancer Care Manitoba
Co-Investigator: Dr. Daniel S. Sitar, Ph.D, University of Manitoba
Co-Investigator: Dr. Paramjit Tappia, Ph.D, Asper Clinical Research Institute
Status: Open
Glioblastoma (GBM)
- CancerCare Manitoba ethics approval obtained for the protocol
- Patients to be recruited newly diagnosed and treated
- Utilize both SSAT1 and new panels
- Expand clinical trial sites in N. America
Breast Cancer
- Identified and validated several putative markers
- Expanding trial samples
- Incorporate other clinical and imaging data
Head / Neck Cancer
- In discussion with a major European centre to develop a comprehensive Omics panel of markers for high relapse cancer cohort
- Modify protocol and potentially extend trial to additional North American sites after Health Canada and ethics approvals are granted.
Customer reviews
No reviews were found for BioMark - Cancer Research Services. Be the first to review!